Gen-Wealth Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-34
Closed -$288 – 801
2026
Q2
$288 Hold
34
– – ﹤0.01% 702
2026
Q1
$185 Hold
34
– – ﹤0.01% 714
2025
Q4
$238 Hold
34
– – ﹤0.01% 677
2025
Q3
$263 Hold
34
– – ﹤0.01% 671
2025
Q2
$296 Hold
34
– – ﹤0.01% 626
2025
Q1
$271 Hold
34
– – ﹤0.01% 601
2024
Q4
$309 Hold
34
– – ﹤0.01% 631
2024
Q3
$301 Hold
34
– – ﹤0.01% 644
2024
Q2
$333 Hold
34
– – ﹤0.01% 626
2024
Q1
$513 Buy
+34
New +$617 ﹤0.01% 605

Other funds holding TDOC

Gen-Wealth Partners's TDOC Position: Q3 2026 in Review

Gen-Wealth Partners sold out of Teladoc Health (TDOC) in Q3 2026, closing a stake of 34 shares — an estimated $288 sold.

Gen-Wealth Partners first reported a position in TDOC in Q1 2024 and held it in 10 quarters. The position peaked at $513 in Q1 2024. 175 funds tracked by Wall St. Rank hold TDOC as of Q3 2026.

  • Gen-Wealth Partners reported no remaining Teladoc Health position as of Q3 2026 after selling out during the quarter.
  • Gen-Wealth Partners sold 34 Teladoc Health shares in Q3 2026, an estimated $288.
  • Gen-Wealth Partners first reported a position in Teladoc Health in Q1 2024 and held it in 10 quarters.
  • Gen-Wealth Partners's Teladoc Health position peaked at $513 in Q1 2024.
  • 175 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2026.

Based on Gen-Wealth Partners's 13F filing for Q3 2026, filed 4 Nov 2026.